Lexicon Pharmaceuticals, Inc.Lexicon Pharmaceuticals, Inc.Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc.

No trades
See on Supercharts
Market capitalization
‪485.09 M‬USD
−0.79USD
‪−177.12 M‬USD
‪1.20 M‬USD
‪239.55 M‬
Beta (1Y)
1.52

About Lexicon Pharmaceuticals, Inc.

CEO
Lonnel Coats
Headquarters
The Woodlands
Employees (FY)
285
Founded
1995
ISIN
US5288723027
FIGI
BBG000BQ85G2
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LXRX is 1.87 USD — it has decreased by 5.08% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Lexicon Pharmaceuticals, Inc. stocks are traded under the ticker LXRX.
Lexicon Pharmaceuticals, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Lexicon Pharmaceuticals, Inc. has a max estimate of 10.00 USD and a min estimate of 2.50 USD.
LXRX earnings for the last quarter are −0.21 USD whereas the estimation was −0.21 USD which accounts for 2.17% surprise. Estimated earnings for the next quarter are −0.22 USD. See more details about Lexicon Pharmaceuticals, Inc. earnings.
Lexicon Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪162.00 K‬ USD despite the estimated figure of ‪2.06 M‬ USD. In the next quarter revenue is expected to reach ‪1.25 M‬ USD.
Yes, you can track Lexicon Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, LXRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lexicon Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
LXRX reached its all-time high on Jul 21, 2000 with the price of 344.75 USD, and its all-time low was 0.92 USD and was reached on Nov 10, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 285.00 employees. See our rating of the largest employees — is Lexicon Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Lexicon Pharmaceuticals, Inc. EBITDA is ‪−171.20 M‬ USD, and current EBITDA margin is ‪−14.22 K‬%. See more stats in Lexicon Pharmaceuticals, Inc. financial statements.